Search results for "Alcohol"

showing 10 items of 1798 documents

Alcohol consumption in Spanish mental health patients vs. working population

2018

Introduction: Alcohol consumption has a high prevalence in society and its chronic consumption is one of the main factors related to health condition in an individual, along with other aspects concerning lifestyle. Regarding the health-disease correlation, it is one of the main determinants of health, from an epidemiological point of view, and has been a traditional object of study from different perspectives and in diverse population groups.Objective: To compare consumption patterns and related variables in two different groups: patients in mental health units and workers in general.Materials and methods: Cross-sectional study in a population of 1 180 service workers and 304 patients in a …

medicine.medical_specialtyPopulationlcsh:MedicineUnit (housing)Salud mentalSalud públicaEnvironmental healthEpidemiologymedicineWorking populationSocial determinants of healtheducationOccupational HealthConsumption (economics)education.field_of_studylcsh:R5-920lcsh:RSalud laboralGeneral MedicineMental healthAlcoholismMental Health61 Ciencias médicas; Medicina / Medicine and healthPublic HealthAlcoholPsychologylcsh:Medicine (General)Alcohol consumptionRevista de la Facultad de Medicina
researchProduct

P-869 - „Two great masqueraders” in a psychiatry clinic - case series of neurosyphilis and neuroborreliosis

2012

Background Neurosyphilis can develop at any stage of syphilis despite of previously recieved treatment, and it can mimic any neuropschychiatric disorder. The psychopathology of neuroborreliosis is less described. Objectives To describe the cases of schizophrenia - like psychosis in patients with these hronic neuroinfections. Methods and materials Retrospective chart review study of five inmates (four with neurosyphilis and one with neuroborreliosis) was performed. Results Psychiatric histories of two females (45 and 49 y.o.) and three males (31, 40, 45 y.o.) are achieved. In four cases they were initially misdiagnosed as paranoid schizophrenia and in one case - as a persistent alcoholic hal…

medicine.medical_specialtyPsychosisParanoid schizophreniaPediatricsbusiness.industrymedicine.diseaseAlcoholic hallucinosisNeurosyphilisPsychiatry and Mental healthSchizophreniaMedicineSyphilisbusinessPsychiatryNeuroborreliosisPsychopathologyEuropean Psychiatry
researchProduct

Advances in Alcoholism Research in Germany

2005

This article presents the proceedings of a symposium at the 2004 International Society for Biomedical Research on Alcoholism meeting in Heidelberg/Mannheim, Germany, put together by the German Society of Addiction Therapy and Research (DG-Sucht e.V.). The aim was to give an overview on recent findings from animal to human studies that were conducted by several research groups engaged in the alcoholism field in Germany for longer periods. Results of his animal studies were presented by J. Wolfgramm; G. Buchringer reported on epidemiologic and psychotherapeutic research advances on alcohol-related disorders in Germany. L. G. Schmidt summarized results of novel diagnostic and therapeutic appro…

medicine.medical_specialtyResearch groupsHuman studiesAddictionmedia_common.quotation_subjectAlcohol dependenceMedicine (miscellaneous)Toxicologylanguage.human_languageGermanPsychiatry and Mental healthlanguagemedicinePersonalityIn patientBig Five personality traitsPsychiatryPsychologymedia_commonClinical psychologyAlcoholism: Clinical & Experimental Research
researchProduct

Influence of different alcohol intake frequencies on alveolar bone loss in adult rats : a sem study

2018

Background Alcohol intake is associated with oral diseases and bone changes including alveolar bone loss in humans and in experimental animals. The main aim of the present study is to assess the effect of long-term alcohol intake, at different frequencies, on periodontal bone loss (PBL) in adult rats. Material and Methods Thirty-six (36) rats were divided into 3 groups: Control (daily water intake, n=12), daily alcohol intake (20% ethanol, n=12), and social alcohol intake (20% ethanol twice a week, n=12). The rats were sacrificed after 90 days and their right maxillae were removed. Initially, a random portion from each group was analyzed through SEM (scanning electron microscope) to assess …

medicine.medical_specialtySem studyAlcohol030226 pharmacology & pharmacy03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicinemedicinePeriodontologyWater intakeGeneral DentistryDental alveolusPeriodontitisEthanolbusiness.industryResearch030206 dentistryFlat bonemedicine.disease:CIENCIAS MÉDICAS [UNESCO]Endocrinologymedicine.anatomical_structurechemistryUNESCO::CIENCIAS MÉDICASAlcohol intakebusiness
researchProduct

Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence

2018

BACKGROUND Gamma-hydroxybutyrate (GHB or sodium oxybate) is both an exogenous and endogenous molecule with neuromodulator properties. In the United States, GHB is an approved drug for the treatment of narcolepsy and narcolepsy with cataplexy in adults. In some European Union countries, sodium oxybate is applied for the treatment of opioid and alcohol withdrawal. OBJECTIVE The aim of the present review was to describe the state of art of the pre-clinical research and the clinical evidence related to GHB used alone or in combination with other treatments in alcohol withdrawal syndrome and alcohol abstinence maintenance. METHOD Internationally published pre-clinical findings and clinical studi…

medicine.medical_specialtySodium Oxybatemedia_common.quotation_subjectClinical Biochemistry01 natural sciencesNaltrexone03 medical and health sciences0302 clinical medicinemedicineHumansmedia_common.cataloged_instance030216 legal & forensic medicineEuropean unionPsychiatrymedia_commonPharmacologyAlcohol Abstinencebusiness.industry010401 analytical chemistryGamma hydroxybutyrategamma-Hydroxybutyric acidAbstinencemedicine.diseaseSubstance Withdrawal Syndrome0104 chemical sciencesAlcohol withdrawal syndromeSodium OxybatebusinessAlcohol-Related DisordersCentral Nervous System AgentsAlcohol Abstinencemedicine.drugCurrent Drug Metabolism
researchProduct

The effect of ezetimibe on NAFLD

2015

NAFLD has become the most common liver disorder in countries, where obesity, type 2 diabetes mellitus, dyslipidemia, and metabolic syndrome are common. The strong association between these conditions and the risk of cardiovascular disease make treatment crucial. Possible interventions for NAFLD target excess body weight, insulin resistance, inflammation, oxidative stress or intestinal lipid absorption. Administration of combination therapy with a statin plus ezetimibe, associated with lifestyle changes, may represent an effective strategy because of the strong reduction in low-density lipoprotein cholesterol levels. Combination therapy is often more effective, especially when complementary …

medicine.medical_specialtyStatinSettore MED/09 - Medicina InternaCombination therapymedicine.drug_classBioinformaticsLiver disorderInsulin resistanceEzetimibeInternal medicineInternal MedicineAnimalsHumansMedicinebusiness.industryAnticholesteremic AgentsIntestinal lipid absorptionnutritional and metabolic diseasesGeneral MedicineLipid Metabolismmedicine.diseaseEzetimibeTreatment OutcomeEndocrinologyCholesterolLiverAzetidinesDrug Therapy CombinationMetabolic syndromebusinessCardiology and Cardiovascular MedicineNon-alcoholic steatohepatitiDyslipidemiamedicine.drugNon-alcoholic fatty liver disease
researchProduct

GLP-1 receptor agonists in NAFLD.

2017

IF 4.101; International audience; Non-alcoholic fatty liver disease (NAFLD) is very common in patients with type 2 diabetes (T2D), with approximately two-thirds having a diagnosis of the disease. Currently, the only validated treatment for NAFLD is weight loss. A number of studies of animal models and human trials have evaluated the effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on liver fat content and suggest that the treatment could represent a new alternative for NAFLD management. In this review, our focus is on the main studies regarding the effects of GLP-1RAs on NAFLD. Also, the mechanisms that might explain their beneficial effects on liver diseases are analyzed.

medicine.medical_specialtySteatosisEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismDiseaseType 2 diabetesGastroenterologyGlucagon-Like Peptide-1 Receptor03 medical and health sciences0302 clinical medicineEndocrinologyFibrosisWeight lossInternal medicineInternal MedicineHumansHypoglycemic AgentsMedicineReceptorGlucagon-like peptide 1 receptorGLP-1 receptor agonistsbusiness.industryFatty livernutritional and metabolic diseasesGeneral Medicine[ SDV.MHEP.EM ] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismmedicine.diseaseFibrosisdigestive system diseasesTreatment OutcomeDiabetes Mellitus Type 2030211 gastroenterology & hepatologytype 2 diabetesSteatosismedicine.symptombusinessNon-alcoholic fatty liver disease
researchProduct

Cognitive effects of labeled addictolytic medications

2017

Abstract Introduction Alcohol, tobacco, and illegal drug usage is pervasive throughout the world, and abuse of these substances is a major contributor to the global disease burden. Many pharmacotherapies have been developed over the last 50 years to target addictive disorders. While the efficacy of these pharmacotherapies is largely recognized, their cognitive impact is less known. However, all substance abuse disorders are known to promote cognitive disorders like executive dysfunction and memory impairment. These impairments are critical for the maintenance of addictive behaviors and impede cognitive behavioral therapies that are regularly administered in association with pharmacotherapie…

medicine.medical_specialtySubstance-Related Disordersmedia_common.quotation_subjectAlcohol abuse03 medical and health scienceschemistry.chemical_compoundCognition0302 clinical medicinemedicineAnimalsHumansVareniclinePsychiatryBiological PsychiatryNalmefenemedia_commonPharmacologyAddictionCognitionmedicine.disease030227 psychiatrySubstance abusechemistryPsychology030217 neurology & neurosurgeryCentral Nervous System AgentsClinical psychologymedicine.drugExecutive dysfunctionBuprenorphineProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

Assessing alcohol consumption through wastewater-based epidemiology: Spain as a case study

2020

Background In this study, an alternative and complementary method to those approaches currently used to estimate alcohol consumption by the population is described. This method, known as wastewater-based epidemiology (WBE), allows back-calculating the alcohol consumption rate in a given population from the concentrations of a selected biomarker measured in wastewater. Methods Composite (24-h) wastewater samples were collected at the inlet of 17 wastewater treatment plants located in 13 Spanish cities for seven consecutive days in 2018. The sampled area covered 12.8% of the Spanish population. Wastewater samples were analyzed to determine the concentration of ethyl sulfate, the biomarker use…

medicine.medical_specialtyWastewater-Based Epidemiological MonitoringAdolescentAlcohol DrinkingAlcohol abusePopulationAlcohol abuseSulfuric Acid EstersWastewaterConsumption patternsToxicologySewage epidemiology03 medical and health sciences0302 clinical medicineEnvironmental healthEpidemiologyPer capitamedicineHumansPharmacology (medical)030212 general & internal medicineCitieseducationLiquid chromatography-mass spectrometryPharmacologyConsumption (economics)education.field_of_studyEthanolQ Science (General)Wastewater based epidemiologymedicine.diseaseHealth SurveysPsychiatry and Mental healthPolicyWastewaterSpainEnvironmental scienceAlcohol consumption030217 neurology & neurosurgeryWater Pollutants Chemical
researchProduct

Blood Alcohol Concentration-Related Lower Performance in Immediate Visual Memory and Working Memory in Adolescent Binge Drinkers

2017

The binge drinking (BD) pattern of alcohol consumption is prevalent during adolescence, a period characterized by critical changes to the structural and functional development of brain areas related with memory and cognition. There is considerable evidence of the cognitive dysfunctions caused by the neurotoxic effects of BD in the not-yet-adult brain. Thus, the aim of the present study was to evaluate the effects of different blood alcohol concentrations (BAC) on memory during late adolescence (18–19 years old) in males and females with a history of BD. The sample consisted of 154 adolescents (67 males and 87 females) that were classified as refrainers if they had never previously drunk alc…

medicine.medical_specialtyWechsler Memory Scaleeducationlcsh:BF1-990030508 substance abuseBinge drinkingblood alcohol concentrationworking memory03 medical and health sciences0302 clinical medicineVisual memoryBlood alcoholmedicinePsychologyimmediate visual memoryadolescentsPsychiatryGeneral PsychologyOriginal ResearchWorking memoryCognitionLate adolescencebinge drinkinglcsh:PsychologyStandard drink0305 other medical sciencePsychology030217 neurology & neurosurgeryFrontiers in Psychology
researchProduct